Literature DB >> 20219857

Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4.

Yunhui Cheng1, Ping Zhu, Jian Yang, Xiaojun Liu, Shimin Dong, Xiaobin Wang, Bao Chun, Jian Zhuang, Chunxiang Zhang.   

Abstract

AIMS: The aims of the present study are to determine the miRNA expression signature in rat hearts after ischaemic preconditioning (IP) and to identify an IP-regulated miRNA, miR-21, in IP-mediated cardiac protection, and the potential cellular and molecular mechanisms involved. METHODS AND
RESULTS: The miRNA expression signature was investigated in rat hearts. Among the 341 arrayed miRNAs, 40 miRNAs were differentially expressed (21 up and 19 down) in rat hearts with IP, compared with their controls. Some of these differentially expressed miRNAs were further verified by quantitative reverse transcriptase-polymerase chain reaction. Remarkably, miR-21 was one of most upregulated miRNAs in hearts after IP. In vivo, IP-mediated cardiac protection against ischaemia/reperfusion injury was inhibited by knockdown of cardiac miR-21. In cultured cardiac myocytes, we identified that miR-21 also had a protective effect on hypoxia/reoxygenation-induced cell apoptosis that was associated with its target gene, programmed cell death 4. The protective effect of miR-21 on cardiac cell apoptosis was further confirmed in rat hearts after ischaemia/reperfusion injury in vivo.
CONCLUSION: The results suggest that miRNAs are involved in IP-mediated cardiac protection. Identifying the roles of IP-regulated miRNAs in cardiac protection may provide novel therapeutic and preventive targets for ischaemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219857      PMCID: PMC2904662          DOI: 10.1093/cvr/cvq082

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  21 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.

Authors:  Victor Ambros
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

3.  The widespread impact of mammalian MicroRNAs on mRNA repression and evolution.

Authors:  Kyle Kai-How Farh; Andrew Grimson; Calvin Jan; Benjamin P Lewis; Wendy K Johnston; Lee P Lim; Christopher B Burge; David P Bartel
Journal:  Science       Date:  2005-11-24       Impact factor: 47.728

4.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

Review 5.  MicroRNAs: a developing story.

Authors:  Amy E Pasquinelli; Shaun Hunter; John Bracht
Journal:  Curr Opin Genet Dev       Date:  2005-04       Impact factor: 5.578

Review 6.  Future use of genomics in coronary artery disease.

Authors:  Samir B Damani; Eric J Topol
Journal:  J Am Coll Cardiol       Date:  2007-10-29       Impact factor: 24.094

7.  MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.

Authors:  Ruirui Ji; Yunhui Cheng; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Circ Res       Date:  2007-05-03       Impact factor: 17.367

8.  MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction.

Authors:  Shimin Dong; Yunhui Cheng; Jian Yang; Jingyuan Li; Xiaojun Liu; Xiaobin Wang; Dong Wang; Thomas J Krall; Ellise S Delphin; Chunxiang Zhang
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

9.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

Authors:  Yunhui Cheng; Ruirui Ji; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

10.  Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.

Authors:  Angie M Cheng; Mike W Byrom; Jeffrey Shelton; Lance P Ford
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

View more
  147 in total

Review 1.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

Review 2.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

3.  Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.

Authors:  David M Patrick; Rusty L Montgomery; Xiaoxia Qi; Susanna Obad; Sakari Kauppinen; Joseph A Hill; Eva van Rooij; Eric N Olson
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

4.  Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training.

Authors:  Aaron L Baggish; Andrew Hale; Rory B Weiner; Gregory D Lewis; David Systrom; Francis Wang; Thomas J Wang; Stephen Y Chan
Journal:  J Physiol       Date:  2011-06-20       Impact factor: 5.182

5.  Ultrasound-targeted microbubble destruction-mediated microRNA-21 transfection regulated PDCD4/NF-κB/TNF-α pathway to prevent coronary microembolization-induced cardiac dysfunction.

Authors:  Q Su; L Li; Y Liu; Y Zhou; J Wang; W Wen
Journal:  Gene Ther       Date:  2015-06-16       Impact factor: 5.250

6.  Overexpression of microRNA-145 protects against rat myocardial infarction through targeting PDCD4.

Authors:  Hao Xu; Heng Cao; Guoqing Zhu; Shaowen Liu; Hongli Li
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 7.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

Review 8.  MicroRNA-21 in the pathogenesis of acute kidney injury.

Authors:  Ya-Feng Li; Ying Jing; Jielu Hao; Nathan C Frankfort; Xiaoshuang Zhou; Bing Shen; Xinyan Liu; Lihua Wang; Rongshan Li
Journal:  Protein Cell       Date:  2013-11-10       Impact factor: 14.870

9.  Mechanism of programmed cell death factor 4/nuclear factor-κB signaling pathway in porcine coronary micro-embolization-induced cardiac dysfunction.

Authors:  Qiang Su; Lang Li; Jiangyou Wang; You Zhou; Yangchun Liu
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

Review 10.  OxymiRs in cutaneous development, wound repair and regeneration.

Authors:  Chandan K Sen; Sashwati Roy
Journal:  Semin Cell Dev Biol       Date:  2012-10-10       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.